Ginder, Curtis R. https://orcid.org/0000-0001-8507-9624
Suero-Abreu, Giselle A.
Ghumman, Saad S.
Bergmark, Brian A.
Arnaout, Omar
Giugliano, Robert P.
Article History
Received: 28 October 2023
Accepted: 17 January 2024
First Online: 27 March 2024
Declarations
:
: Dr. Bergmark has received institutional research grant support through Brigham and Women’s Hospital from Pfizer, Ionis, AstraZeneca, Philips, Abbott Vascular, SpectraWAVE, and Inari. Dr. Bergmark reports consulting fees from Abiomed, Abbott Vascular, Bain Life Sciences, Endovascular Engineering, Terumo, and SpectraWAVE. Dr. Giugliano receives clinical trial and research support from Amgen, Anthos Therapeutics, Daiichi-Sankyo, and Ionis; honoraria for lectures or the continuing medical education program from Amgen, Centrix, Daiichi-Sankyo, Dr. Reddy’s Laboratories, Medical Education Resources, Medscape, Menarini, Merck, Pfizer, SAJA Pharmaceuticals, Servier, Shanghai Medical Telescope, and Voxmedia; and is a consultant for Amarin, Amgen, Bayer, Boston Scientific, Caladrius, CryoLife, CSL Behring, CVS Caremark, Daiichi Sankyo, Esperion, Gilead, Hen-grui, Inari, Janssen, Novartis, Paratek, Pfizer, PhaseBio Pharmaceuticals, and Samsung. Dr. Giugliano is an Editor-in-Chief of Cardiology and Therapy. Dr. Giugliano was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions. Dr. Curtis Ginder, Dr. Giselle Suero-Abreu, Dr. Saad Ghumman, and Dr. Omar Arnaout have no disclosures.
: The patient presented in this case report granted written informed consent and permission for publication of his clinical course.